Searched for
MOLBIO DIAGNOSTICS SHARE PRICE TARGET
Jefferies cuts KEI Industries target price by 11%. Will UltraTech’s entry put the company at risk?Jefferies has cut its target price for KEI Industries by 11% to Rs 6,150, citing concerns over UltraTech Cement’s entry into wires and cabl...- Bernstein names Paytm stock as its top pick, lists 3 strong growth drivers for fintech giantBernstein has named Paytm its top pick, citing strong merchant lending growth, operating leverage and potential UPI MDR as key earnings dri...
- BSE shares fall 3% as rival NSE gets closer to mega IPO. More pain ahead?BSE shares fell on Friday after rival NSE announced its Rs 22,662-crore IPO, with the issue set to open on September 17. Bernstein has an ‘...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Vodafone Idea shares price in focus as Jefferies initiates coverage with Buy rating. Why are analysts bullish?Jefferies has initiated coverage on Vodafone Idea with a ‘Buy’ rating and a Rs 20 price target, implying 29% upside. The brokerage expects ...
- HFCL shares hit lower circuit after 240% rally in 2026. What technical charts now indicateHFCL shares hit the 5% lower circuit on Thursday, extending their two-day decline to 7% despite a 240% rally so far in 2026. The stock is c...
- Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The ...
- Explained: Why Bernstein prefers MCX over BSE as volumes plummet amid CAS chaosBernstein has favoured MCX over BSE as commodity derivatives volumes maintain strong momentum while equity derivatives activity weakens ami...
- India’s textile boom ahead? Why Jefferies is bullish on Welspun, RaymondJefferies upgraded Welspun Living to Buy and more than doubled its target to Rs 260, while initiating coverage on Raymond Lifestyle with a ...
- BSE shares fall 4% to snap 3-day rally as Bernstein forecasts up to 17% downsideBSE shares fell sharply on Wednesday after Bernstein initiated coverage with an Underperform rating and a Rs 2,820 target, implying 17% dow...
- Two Trades for Today: A top PSU engineering consultancy for a 6.15% upmove, a mid-cap diagnostics stock for gain of almost 6%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- How 90% IPOs in August beat volatile India market to return up to 72% after listingIn August, a majority of newly listed IPOs saw a successful debut, outpacing the broader market. Approximately ninety percent of these list...
- Molbio Diagnostics shares rally 6% after strong debut. What should investors do?Molbio Diagnostics made a strong debut, beating grey market expectations. Experts remain positive on the company’s molecular diagnostics le...
- Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSEMolbio Diagnostics Share Price: Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO price of Rs 8...
- Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check statusMolbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market pre...
- Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?Molbio Diagnostics IPO: Point-of-care molecular diagnostics company Molbio Diagnostics saw strong investor response for its IPO, drawing as...
- Molbio Diagnostics IPO Day 2: GMP hits at 17% listing gains. Should you bid?Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GM...
- Dhoot, Milky Mist or Molbio? What should investors pick in Rs 7,000 crore IPO rush this weekThis week, India's IPO market shines brightly as five firms successfully raise over Rs 7,000 crore. Analysts highlight Dhoot Transmission a...
- Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...
- World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor roundMolbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 cr...
Load More
